Uncertainty of Measurement Summary Table for Specialist Techniques
For acetylcholine receptor antibodies, GAD antibodies (for diabetes and Stiff Persons’ Syndrome), intrinsic factor antibodies and functional antibodies.
For acetylcholine receptor antibodies, GAD antibodies (for diabetes and Stiff Persons’ Syndrome), intrinsic factor antibodies and functional antibodies.
For C1 inhibitor quantitative assay and serum free light chains.
Further information on the delay in release of IA2 and ZnT8 antibody results is provided below, alongside guidance for their interpretation.
Updated course programme
NHSGGC Alcohol and Drugs Health Improvement Team Snapshot – April 2024
CLEANING THE ASEPTIC ROOM AND ISOLATOR USED TO PREPARE GENETICALLY MODIFIED ORGANISM PRODUCTS (GMO) For Password contact Lead Pharmacist Clinical Trials R&I
INTRODUCTION TO GENETICALLY MODIFIED ORGANISM (GMO) PRODUCTS WITHIN CLINICAL TRIALS For Password contact Lead Pharmacist Clinical Trials R&I
Tracking and Release of IMPs placed into quarantine post delivery at pharmacy sites For Password contact Lead Pharmacist Clinical Trials R&I
Clinical Trial Information Provided to Site On-Call Pharmacists For Password contact Lead Pharmacist Clinical Trials R&I
Management of controlled drug IMPs within pharmacy sites For Password contact Lead Pharmacist Clinical Trials R&I